Pfizer News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

01.03.23	FDA Panel Backs Pfizer RSV Vaccine For Older Adults (RTTNews)
28.02.23	Pfizer Receives Positive FDA Advisory Committee Votes Supporting Potential Approval for Vaccine Candidate to Help Combat RSV in Older Adults (Businesswire)
27.02.23	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
27.02.23	Pfizer In Talks To Buy Seagen : Report (RTTNews)
22.02.23	Pfizer: FDA Grants Priority Review For BLA For Elranatamab (RTTNews)
22.02.23	Pfizer’s Elranatamab Receives FDA and EMA Filing Acceptance (Businesswire)
21.02.23	Pfizer: FDA Accepts For Review BLA For Respiratory Syncytial Virus Vaccine Candidate (RTTNews)
21.02.23	U.S. FDA Accepts Biologics License Application for Pfizer’s Respiratory Syncytial Virus Maternal Vaccine Candidate for Priority Review (Businesswire)
16.02.23	Pfizer Reports Positive Data From Phase 3 Trial Of Talzenna/Xtandi Combo (RTTNews)
16.02.23	Pfizer Announces Positive TALZENNA® and XTANDI® Combination Data from Phase 3 TALAPRO-2 Study (Businesswire)
16.02.23	Pfizer Announces The Lancet Neurology Has Published Phase 3 Data for Zavegepant for the Acute Treatment of Migraine in Adults (Businesswire)
10.02.23	Pfizer, BioNTech Start Phase 1/2 Study Of First MRNA-based Shingles Vaccine Program (RTTNews)
10.02.23	Pfizer's Atopic Dermatitis Drug Cibinqo Label Expanded In U.S. To Include Adolescents (RTTNews)
10.02.23	FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib) (Businesswire)
09.02.23	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
31.01.23	Pfizer Q4 Profit Tops View; Sees Weak FY23 Results, Below Market (RTTNews)
31.01.23	Pfizer Inc. Q4 Profit Increases, beats estimates (RTTNews)
31.01.23	PFIZER REPORTS RECORD FULL-YEAR 2022 RESULTS AND PROVIDES FULL-YEAR 2023 FINANCIAL GUIDANCE (Businesswire)
27.01.23	FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots (RTTNews)
17.01.23	Pfizer Expands Product Offering In Accord Initiative To Around 500 Products (RTTNews)
17.01.23	Pfizer Expands ‘An Accord for a Healthier World’ Product Offering to Include Full Portfolio for Greater Benefit to 1.2 Billion People in 45 Lower-Income Countries (Businesswire)
06.01.23	Pfizer's SBLA For 20vPnC Vaccine In Infants And Children Accepted By FDA For Priority Review (RTTNews)
06.01.23	U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Pfizer’s 20-Valent Pneumococcal Conjugate Vaccine in Infants and Children (Businesswire)
03.01.23	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
29.12.22	Pfizer Announces Positive Results From Late-stage Study Of Hemophilia B Gene Therapy Candidate (RTTNews)
29.12.22	Pfizer : FDA Accepts For Review BLA For Pentavalent Meningococcal Vaccine Candidate In Adolescents (RTTNews)
28.12.22	U.S. FDA Accepts for Review the Biologics License Application for Pfizer’s Investigational Pentavalent Meningococcal Vaccine Candidate (MenABCWY) in Adolescents (Businesswire)
28.12.22	Pfizer's Hospira Recalls Vancomycin Injection (RTTNews)
22.12.22	ORIC Pharma Collaborates With Pfizer For Phase 2 Study Of ORIC-533 In Multiple Myeloma; Stock Up (RTTNews)
21.12.22	Pfizer : FDA And EMA Accept Etrasimod Regulatory Submissions For Ulcerative Colitis (RTTNews)
21.12.22	Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis (Businesswire)
20.12.22	Pfizer Invites Public to View and Listen to Webcast of January 31 Conference Call with Analysts (Businesswire)
14.12.22	Roche Collaborates With Pfizer To Educate On Importance Of Timely COVID-19 Testing (RTTNews)
10.12.22	Pfizer Presents Updated Favorable Elranatamab Data from Pivotal Phase 2 MagnetisMM-3 Trial (Businesswire)
09.12.22	Pfizer Declares First-Quarter 2023 Dividend (Businesswire)
08.12.22	FDA Authorizes Updated Covid Vaccines For Children As Young As 6 Months Old (RTTNews)
08.12.22	Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years (Businesswire)
07.12.22	Pfizer Announces FDA Priority Review For Respiratory Syncytial Virus Vaccine Candidate (RTTNews)
07.12.22	U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults (Businesswire)
06.12.22	Pfizer, Clear Creek Bio Ink Research Collaboration To Develop Oral Treatment For COVID-19 (RTTNews)
06.12.22	Pfizer and Clear Creek Bio to Collaborate on a Research Program Targeting SARS-CoV-2 Papain-Like Protease (Businesswire)
06.12.22	Pfizer Seeks FDA Approval For Bivalent COVID-19 Vaccine In Kids Under 5 (RTTNews)
01.12.22	Pfizer Invites Public to Register for Webcast of Pfizer Near-Term Launches + High-Value Pipeline Day (Businesswire)
01.12.22	Roivant Forms New Vant With Pfizer To Develop PF-06480605 For Inflammation Diseases (RTTNews)
01.12.22	Valneva, Pfizer Report 6-Month Antibody Persistence Data For Lyme Disease Vaccine Candidate (RTTNews)
28.11.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
16.11.22	Form 4 78003 (RSS)
11.11.22	Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference (Businesswire)
09.11.22	Form 10-Q 78003 (RSS)
04.11.22	Pfizer, BioNTech Reveal Updated Data For Omicron BA.4/BA.5-Adapted Bivalent Booster (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus
22.11.24		Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone
22.11.24		Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen
22.11.24		Handel in Frankfurt: TecDAX letztendlich in Grün
22.11.24		Freundlicher Handel: Börsianer lassen SPI schlussendlich steigen

22.11.24

Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone

22.11.24

Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester

22.11.24

Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus

22.11.24

Zuversicht in London: FTSE 100 beendet die Freitagssitzung in der Gewinnzone

22.11.24

Gute Stimmung in Europa: Anleger lassen STOXX 50 letztendlich steigen

22.11.24

Handel in Frankfurt: TecDAX letztendlich in Grün